Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

United Arab Emirates

United Arab Emirates Articles

Industry

BMI View: Attempts in the Gulf region to take a more preventative stance against public health issues is commendable, but changing attitudes and weaning the population of their tobacco... 2012-02-01


Industry

BMI View: The recent increase in immigration to the UAE is good for total market size but increasingly it is becoming divided between indigenous nationals/expatriate professionals and... 2012-01-05


Industry

BMI View: As the Gulf Cooperation Council (GCC) is pushing the financial burden of healthcare on to individuals, through the mandating of compulsory health insurance, regulations will... 2011-11-21


More ARTICLES

Industry

BMI View: While emerging pharmaceutical markets are a fantastic growth story, the use of higher prices for drugs in emerging markets to offset the austerity of Europe and US healthcare... 2011-11-18


Industry

BMI View: While the biotechnology parks of Dubai and Saudi Arabia have attracted some big names in the global industry, we are concerned that they may have become glorified tax havens... 2011-11-09


Industry

BMI View: The rise of lifestyle diseases associated with obesity and the relatively high per capita spending of the Gulf Cooperation Council (GCC) countries is going to attract medical... 2011-10-26


Industry

BMI View: A free trade agreement (FTA) between India and the Gulf Cooperation Council (GCC) will help Indian drugmakers to take a greater market share of the generic drug segment, primarily... 2011-10-13


Industry

BMI Core View: Corporate social responsibility (CSR) is an under-appreciated business activity in the pharmaceutical industry. Like all commercial entities, drugmakers are fully entitled... 2011-09-26

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries